Heme iron polypeptide and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Heme iron polypeptide and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: heme iron polypeptide
Brand name: Proferrin-ES
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Heme iron polypeptide-Insulin degludec
- Heme iron polypeptide-Insulin Degludec (U-100) Prefilled Pens
- Heme iron polypeptide-Insulin Degludec (U-100) Vials
- Heme iron polypeptide-Insulin Degludec (U-200) Prefilled Pens
- Heme iron polypeptide-Insulin degludec and liraglutide
- Heme iron polypeptide-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-HemeNatal OB
- Insulin aspart, recombinant Subcutaneous-HemeNatal OB plus DHA
- Insulin aspart, recombinant Subcutaneous-HemeTab
- Insulin aspart, recombinant Subcutaneous-Hemin
- Insulin aspart, recombinant Subcutaneous-Hemin Intravenous
- Insulin aspart, recombinant Subcutaneous-Hemlibra